NIBEC | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
2,272
4,786
4,174
4,804
6,303
Cost of Goods Sold (COGS) incl. D&A
2,571
3,706
3,309
4,060
4,553
Gross Income
299
1,080
865
744
1,750
SG&A Expense
2,326
4,090
2,431
3,230
2,861
EBIT
2,637
3,025
1,584
2,500
1,151
Unusual Expense
-
-
739
553
710
Non Operating Income/Expense
2
661
92
52
121
Interest Expense
521
549
464
713
624
Pretax Income
3,086
3,621
2,479
3,120
2,595
Income Tax
764
-
53
93
28
Consolidated Net Income
3,850
3,621
2,426
3,027
2,568
Net Income
3,850
3,621
2,426
3,027
2,568
Net Income After Extraordinaries
3,850
3,621
2,426
3,027
2,568
Net Income Available to Common
3,850
3,621
2,426
3,027
2,568
EPS (Basic)
1,071.17
975.67
534.00
578.00
463.00
Basic Shares Outstanding
4
4
5
5
6
EPS (Diluted)
1,071.37
975.69
533.58
578.47
462.50
Diluted Shares Outstanding
4
4
5
5
6
EBITDA
1,760
1,932
434
1,180
279
Other Operating Expense
12
14
18
15
39
Non-Operating Interest Income
70
31
29
41
10

About NIBEC

View Profile
Address
116 Bamdi-gil
Jincheon NC 27816
Korea, Republic Of
Employees -
Website http://www.nibec.co.kr
Updated 09/14/2018
NIBEC Co., Ltd. engages in the development, manufacture, and commercialization of medical products and supplies. Its business areas include oral care products, bio materials for tissue regeneration, cosmetics and bio fusion peptide businesses. The Oral Care Products business offers tooth whitening, tooth desensitizer and dental conditioner.